Personalized Treatments and Their Impact on the Arteriovenous Malformation Market
Personalized treatment approaches are transforming the Arteriovenous Malformation Market. Customized therapies based on patient-specific AVM characteristics improve safety, efficacy, and recovery outcomes.
Hospitals and specialty centers increasingly use imaging-guided, minimally invasive techniques to deliver personalized care. This trend enhances patient satisfaction, drives adoption of advanced technologies, and fuels market growth globally.
Market Outlook: Valued at USD 1.1 billion in 2024, the market is expected to reach USD 2.4 billion by 2034, growing at a 7.0% CAGR.